RXULTI brexpiprazole

Swiss trademark · 681593 · Combined mark · In force

Register entry

Registration number
681593
Application number
61340/2015
Status
In force
Type
Combined mark
As registered
RXULTI brexpiprazole ((fig.))
Filed
Sep 17, 2015
Registered
Dec 15, 2015
Published
Dec 15, 2015
Protected until
Sep 17, 2035
Colours claimed
Grün, dunkelgrün, hellgrün, gelb, gold, orange.
Priority
01.04.2015 DK
Language of procedure
German
Vienna classes
14.01.13, 14.01.15, 26.03.02, 26.03.04, 26.03.07, 26.03.19, 26.15.13
Source
Swissreg

Goods and services

Pharmaceuticals

Pharmazeutische Präparate für die Behandlung und Vorbeugung von Krankheiten und Störungen des zentralen Nervensystems; pharmazeutische Präparate.

History

What the Federal Institute of Intellectual Property published about this title, newest first.

  1. Jun 12, 2025

    Renewed

    Expiry date
    17.09.2025 → 17.09.2035

    Published in Swissreg on 12.06.2025

  2. May 16, 2022

    Agent’s address changed

    Representative
    RENTSCH PARTNER AG, Bellerivestrasse 203, Postfach, 8034 Zürich → RENTSCH PARTNER AG, Kirchenweg 8, Postfach, 8034 Zürich

    Published in Swissreg on 16.05.2022

  3. Sep 13, 2017

    Agent’s address changed

    Representative
    Rentsch Partner AG, Fraumünsterstrasse 9, Postfach 2441, 8022 Zürich → RENTSCH PARTNER AG, Bellerivestrasse 203, Postfach, 8034 Zürich

    Published in Swissreg on 13.09.2017

  4. Dec 15, 2015

    Registered

    Published in Swissreg on 15.12.2015

Parties

Holder

Otsuka Pharmaceutical Co., Ltd.

2-9 Kanda-Tsukasamachi, Chiyoda-ku, Tokyo, JP

Agent

RENTSCH PARTNER AG

Kirchenweg 8 Postfach, 8034 Zürich

The register names each party by name and address. A party is linked to an organization where exactly one entity of the commercial register bears its name; the street of a party not so recognised is not shown here.